These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 38823344

  • 21. Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy.
    Zheng B, Qian F, Wang X, Wang Y, Zhou B, Fang L.
    J Exp Clin Cancer Res; 2024 Jun 26; 43(1):177. PubMed ID: 38926803
    [Abstract] [Full Text] [Related]

  • 22. Leonurine improves atherosclerosis by activating foam cell autophagy and metabolic remodeling via METTL3-mediated AKT1S1 mRNA stability modulation.
    Yu X, Zhang Y, Wang J, Wang X, Chen X, Yin K, Zhu X.
    Phytomedicine; 2024 Nov 26; 134():155939. PubMed ID: 39214016
    [Abstract] [Full Text] [Related]

  • 23. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
    Chang CH, Bijian K, Wernic D, Su J, da Silva SD, Yu H, Qiu D, Asslan M, Alaoui-Jamali MA.
    Autophagy; 2019 Aug 26; 15(8):1376-1390. PubMed ID: 30773992
    [Abstract] [Full Text] [Related]

  • 24. XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer.
    Xu S, Sun X, Luo L, Yang Y, Guo Q, Tang S, Jiang Z, Li Y, Han J, Gan W, Yang F, Zhang X, Liu Y, Sun C, He J, Liu M, Zuo D, Zhu W, Wu Y.
    Biomed Pharmacother; 2022 Nov 26; 155():113537. PubMed ID: 36113258
    [Abstract] [Full Text] [Related]

  • 25. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
    Guo C, Zhang M, Jin X, Zhu C, Qian J, Tao M.
    Cell Biochem Funct; 2024 Jun 26; 42(4):e4020. PubMed ID: 38702967
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD, Hamurcu Z, Delibaşı N, Çınar V, Güler A, Gökçe S, Nurdinov N, Ozpolat B.
    Anticancer Agents Med Chem; 2021 Jun 26; 21(3):355-364. PubMed ID: 32767958
    [Abstract] [Full Text] [Related]

  • 29. ADT-OH exhibits anti-metastatic activity on triple-negative breast cancer by combinatorial targeting of autophagy and mitochondrial fission.
    Yu S, Cao Z, Cai F, Yao Y, Chang X, Wang X, Zhuang H, Hua ZC.
    Cell Death Dis; 2024 Jun 28; 15(6):463. PubMed ID: 38942765
    [Abstract] [Full Text] [Related]

  • 30. Tanshinone I improves TNBC chemosensitivity by suppressing late-phase autophagy through AKT/p38 MAPK signaling pathway.
    Tang X, Gong J, Ren L, Wang Z, Yang B, Wang W, Wang N.
    Biomed Pharmacother; 2024 Aug 28; 177():117037. PubMed ID: 38959602
    [Abstract] [Full Text] [Related]

  • 31. N6-Methyladenosine Modulates Nonsense-Mediated mRNA Decay in Human Glioblastoma.
    Li F, Yi Y, Miao Y, Long W, Long T, Chen S, Cheng W, Zou C, Zheng Y, Wu X, Ding J, Zhu K, Chen D, Xu Q, Wang J, Liu Q, Zhi F, Ren J, Cao Q, Zhao W.
    Cancer Res; 2019 Nov 15; 79(22):5785-5798. PubMed ID: 31530567
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells.
    Lai X, Wei J, Gu XZ, Yao XM, Zhang DS, Li F, Sun YY.
    J Cell Mol Med; 2021 May 15; 25(9):4248-4259. PubMed ID: 33749070
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW, Yeh YL, Wang YC, Huang WJ, Ho SY, Lin P, Wang YJ.
    Mol Cancer; 2016 Jun 10; 15(1):46. PubMed ID: 27286975
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.
    Xie W, Zhao H, Wang F, Wang Y, He Y, Wang T, Zhang K, Yang H, Zhou Z, Shi H, Wang J, Huang G.
    J Exp Clin Cancer Res; 2021 Jan 12; 40(1):30. PubMed ID: 33436039
    [Abstract] [Full Text] [Related]

  • 38. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, Li C, Sun L, Qin J, Xu T, He B, Pan Y, Sun H, Wang S.
    Mol Cancer; 2020 Jun 17; 19(1):106. PubMed ID: 32552762
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models.
    Cocco S, Leone A, Roca MS, Lombardi R, Piezzo M, Caputo R, Ciardiello C, Costantini S, Bruzzese F, Sisalli MJ, Budillon A, De Laurentiis M.
    J Transl Med; 2022 Jun 27; 20(1):290. PubMed ID: 35761360
    [Abstract] [Full Text] [Related]

  • 40. E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51.
    Liu P, Zhou W, Yang L, Zhang C.
    Chem Biol Interact; 2022 Feb 25; 354():109798. PubMed ID: 34998818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.